{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T04:59:14Z","timestamp":1755925154665},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,2,14]],"date-time":"2002-02-14T00:00:00Z","timestamp":1013644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/1471-2369-3-2","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:42:27Z","timestamp":1034361747000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-\u03b2, and nitrite excretion"],"prefix":"10.1186","volume":"3","author":[{"given":"Liora","family":"Adler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Futterweit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard G","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford E","family":"Kashtan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"MD","given":"Howard","family":"Trachtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,2,14]]},"reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan CE: Alport Syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998, 9: 1736-1750.","journal-title":"J Am Soc Nephrol"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA: Transforming growth factor-\u03b2 in tissue fibrosis. N Engl J Med. 1994, 331: 1286-1292. 10.1056\/NEJM199411103311907.","journal-title":"N Engl J Med"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/ki.1996.65","volume":"49","author":"T Yamamoto","year":"1996","unstructured":"Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA: Expression of transforming growth factor-\u03b2 isoforms in human glomerular diseases. Kidney Int. 1996, 49: 461-469.","journal-title":"Kidney Int"},{"key":"5_CR4","first-page":"F364","volume":"272","author":"WG Haynes","year":"1997","unstructured":"Haynes WG, Hand MF, Dockrell MEC, Eadington DW, Lee MR, Hussein Z, Benjamin N, Webb DJ: Physiological role of nitric oxide in regulation of renal function in humans. Am J Physiol. 1997, 272: F364-F371.","journal-title":"Am J Physiol"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1046\/j.1523-1755.2000.00281.x","volume":"58","author":"RJ Schmidt","year":"2000","unstructured":"Schmidt RJ, Baylis C: Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 2000, 58: 1261-1266. 10.1046\/j.1523-1755.2000.00281.x.","journal-title":"Kidney Int"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","volume":"57","author":"MW Taal","year":"2000","unstructured":"Taal MW, Brenner BM: Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 2000, 57: 1803-1817. 10.1046\/j.1523-1755.2000.00031.x.","journal-title":"Kidney Int"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev.ph.57.030195.001431","volume":"57","author":"M Ketteler","year":"1995","unstructured":"Ketteler M, Noble NA, Border WA: Transforming growth factor-\u03b2 and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis?. Ann Rev Physiol. 1995, 57: 279-295. 10.1146\/annurev.physiol.57.1.279.","journal-title":"Ann Rev Physiol"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1053\/ajkd.2000.19078","volume":"36","author":"GT Shin","year":"2000","unstructured":"Shin GT, Kim SJ, Ma KA, Kim HS, Kim D: ACE inhibitors attenuate expression of renal transforming growth factor-\u03b2 in humans. Am J Kidney Dis. 2000, 36: 894-902.","journal-title":"Am J Kidney Dis"},{"key":"5_CR9","first-page":"F197","volume":"267","author":"M Ketteler","year":"1994","unstructured":"Ketteler M, Border WA, Noble NA: Cytokines and L-arginine in renal injury and repair. Am J Physiol. 1994, 267: F197-F207.","journal-title":"Am J Physiol"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/ki.1997.214","volume":"51","author":"LL Wu","year":"1997","unstructured":"Wu LL, Cox A, Roe CJ, Dziadek M, Cooper ME, Gilbert RE: Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int. 1997, 51: 1553-1567.","journal-title":"Kidney Int"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0272-6386(97)90038-X","volume":"29","author":"C Zoja","year":"1997","unstructured":"Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis. 1997, 29: 254-264.","journal-title":"Am J Kidney Dis"},{"key":"5_CR12","first-page":"F1092","volume":"279","author":"J Schwobel","year":"2000","unstructured":"Schwobel J, Fischer T, Lanz B, Mohaupt M: Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells. Am J Physiol. 2000, 279: F1092-F1100.","journal-title":"Am J Physiol"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock CB, Edelmann CM, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976, 58: 259-263.","journal-title":"Pediatrics"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0022-3476(85)80697-1","volume":"106","author":"GJ Schwartz","year":"1985","unstructured":"Schwartz GJ, Gauthier BG: A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985, 106: 522-526.","journal-title":"J Pediatr"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1542\/peds.98.4.649","volume":"98","author":"National High Blood Pressure Education Program Working Group","year":"1996","unstructured":"National High Blood Pressure Education Program Working Group: Update on the 1987 task force report on high blood pressure in children an adolescents: A working group report from the national high blood pressure education program. Pediatrics. 1996, 98: 649-658.","journal-title":"Pediatrics"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJM199204023261402","volume":"326","author":"RJ Falk","year":"1992","unstructured":"Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC: Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med. 1992, 326: 910-915.","journal-title":"N Engl J Med"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2337\/diacare.23.5.664","volume":"23","author":"E Korpinen","year":"2000","unstructured":"Korpinen E, Akerblom HK, Teppo AM, Gronhagen-Riska C, Hukkanen L, Vaarala O: Urinary transforming growth factor-\u03b21 and \u03b11-microglobulin in children and adolescents with type I diabetes. Diabetes Care. 2000, 23: 664-668.","journal-title":"Diabetes Care"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1507\/endocrj.46.421","volume":"46","author":"S Kurioka","year":"2000","unstructured":"Kurioka S, Koshimura K, Sugitani M, Murakami Y, Nishiki M, Kato Y: Analysis of urinary nitric oxide metabolites in healthy subjects. Endocrine J. 2000, 46: 421-428.","journal-title":"Endocrine J"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1046\/j.1523-1755.1999.00744.x","volume":"56","author":"R Sayers","year":"1999","unstructured":"Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D: Role for transforming growth factor-betal in Alport renal disease progression. Kidney Int. 1999, 56: 1662-1673. 10.1046\/j.1523-1755.1999.00744.x.","journal-title":"Kidney Int"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0002-9440(10)64802-X","volume":"157","author":"D Cosgrove","year":"2000","unstructured":"Cosgrove D, Rodgers K, Meehan D, Miller C, Bovard K, Gilroy A, Gardner H, Kotelianski V, Gotwals P, Amatucci G, et al: Integrin alpha beta 1 and transforming growth factor-beta 1 play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol. 2000, 157: 1649-1659.","journal-title":"Am J Pathol"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s004310051301","volume":"159","author":"W Proesmans","year":"2000","unstructured":"Proesmans W, Knockaert H, Trouet D: Enalapril in pediatric patients with Alport syndrome: 2 years' experience. Eur J Pediatr. 2000, 159: 430-433. 10.1007\/s004310051301.","journal-title":"Eur J Pediatr"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-3-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-3-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-3-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-3-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:32:22Z","timestamp":1726241542000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-3-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-3-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2002,2,14]]},"assertion":[{"value":"7 December 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}